Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia (Q24246379)

inferred from title

cognitive dysfunction

1 reference

inferred from title

author

Bernadette McGuinness

1

object named as

Bernadette McGuinness

0 references

author name string

Stephen Todd

2

0 references

Peter Passmore

3

0 references

Roger Bullock

Cochrane Database of Systematic Reviews

4

0 references

publication date

19 April 2006

0 references

published in

0 references

cites work

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

The effects of antihypertensive treatment on cognitive function: results from the HOPE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

The age-dependent relation of blood pressure to cognitive function and dementia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Is there bias in the publication of individual patient data meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Bias in treatment assignment in controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

A multicenter, double-blind, randomized, placebo-controlled study of isradipine and methyldopa as monotherapy or in combination with captopril in the treatment of hypertension. The LOMIR-MCT-IH Research Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Reexamining the quality of life of hypertensive patients. A new self-structured measure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Effects of adjusting for censoring on meta-analyses of time-to-event outcomes.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Blood pressure and cognitive performance. The Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Quality of life of elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur trial. Syst-Eur Trial Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021

One-year study of felodipine or placebo for stage 1 isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004034.PUB2

7 January 2021